Navigation Links
Another Sexual Attraction is Possible ...

The coming summer vibrates with expressions of insect love and desire. The cicada's songs or the butterflies' bright colours are examples of how an emitting sex attracts conspecific members of the responding sex. Moth odours (pheromones), though less conspicuous for us humans, are also signals by which females guide males towards them, even on the darkest nights. Such mating recognition systems tend to be very specific, hence they are thought to play a major role in the evolution of mating barriers and in the formation of new species.

The fact that conspecific males and females recognize each other by their common use of a highly specific "language" is likely to decrease the fitness of mutants that might use slightly different signals. Such "atypical" individuals would either - and most probably - die without leaving any offspring, or - in the unlikely event that they find a mutant partner - they might found a new line that may eventually become a new species. As such, the offspring of such parents would inherit the mutant communication system of their parents, which could "spark" the divergence leading to the formation of a new species.

The European corn borer, Ostrinia nubilalis, is a model species that is particularly well-suited to study the first steps along the road to speciation and the deep mysteries of reciprocal attraction - or lack thereof - between potentially interfertile individuals. Indeed, two types of females and two corresponding types of males coexist within this species: one type communicates with the so-called "E" pheromone while the other communicates with the "Z" pheromone. Although hybrid matings produce perfectly viable offspring, both types very rarely mate in nature. At a first glance, it is tempting to believe that this is due to their different pheromones.

However, in a study published in the June 20th issue of the online, open-access journal PLoS ONE, researchers from the Institut National de l
'"/>




Page: 1 2

Related medicine news :

1. Another ray of hope for Arthritis Sufferers
2. Another injectable contraceptive Pill approved by FDA
3. The Possibility Of Fighting HIV with Another Virus Questioned
4. New Research Has Found Another Use For Botox
5. Yet Another Harmful Consequence Of Smoking
6. Another Treatment Option for Benign Tumors
7. Yet Another Treatment Option For Cancer
8. Another Alternative For Diabetics On Insulin
9. Another Use For Epilepsy Drugs
10. Another Cause of Thyroid Cancer Discovered
11. Yet Another Use For Cell Phone Cameras
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Another Sexual Attraction Possible

(Date:5/12/2008)...all/ -- Medarex, Inc.,(Nasdaq: MEDX ) announced t...arch 31, 2008., Including a gain of $151.8 millio...million shares of Genmab A/S stock in February 200...h 31, 2008, was $103.3 million, or,$0.81 per share...r $0.88,per share for the same period in 2007. In ...
(Date:5/12/2008)...all/ -- MedCath Corporation,(Nasdaq: MDTH ), a he...are,services, predominantly the diagnosis and trea...hat Art Parker, Senior Vice-President and,Treasure...as been named,Senior Vice-President, Finance and D...le, Art will continue to oversee and direct Treasu...
(Date:5/12/2008)...swire/ -- The American,Veterinary Medical Associat...d dehorning of cattle to provide veterinarians wit... with these procedures. The revised policy,approv...tioners use any,particular method of pain manageme...ndations for consideration by practitioners when t...
(Date:5/12/2008)...Over Tobacco, WASHINGTON, May 9 /PRNewswire-USN...based organization in the country, today announces...revention and Tobacco Control,Act." The legislatio...ucts., "We encourage Congress to pass this impo...i-partisan support and could genuinely help our,pe...
Breaking Medicine News(10 mins):Health News:Medarex Announces 2008 First Quarter Financial Results 2Health News:Medarex Announces 2008 First Quarter Financial Results 3Health News:Medarex Announces 2008 First Quarter Financial Results 4Health News:Medarex Announces 2008 First Quarter Financial Results 5Health News:Medarex Announces 2008 First Quarter Financial Results 6Health News:Medarex Announces 2008 First Quarter Financial Results 7Health News:Medarex Announces 2008 First Quarter Financial Results 8Health News:MedCath Names Parker to New Finance Post 2Health News:Revised AVMA Policy on Castrating and Dehorning Cattle Provides Additional Guidance for Managing Pain 2
...cted on petrochemical workers health and their ret...arly have nearly double the death rate of those wh...pproves the existing misconception that people who...er and happier lives as a consequence. Men were f...
...ly associated with good health and vitality. Howev...the body to manufacture vitamin D. //It doesn't ta... use certainly far less than it takes to get a su... better understand the complex motivations involve...
...in is being hailed as a new 'wonder drug' after it...cancer patients. New results of the trials show th...or the cancer, something that has never happened s...h tracked 5,000 patients in 39 countries, research...
...urvey conducted by Synovate India and sponsored by...gh Indians use high quality toothbrush and the lat...l of oral hygiene awareness was surprisingly low. ...tted that they have never been to a dentist in the...
Other Medicine News:
(Date:5/8/2008)...ovement in ADHD symptoms in adults, WASHINGTON, M...,Nasdaq: SHPGY), the global specialty biopharmace...hase III pivotal study in which VYVANSE,demonstrat...yperactivity,Disorder (ADHD) symptoms in adults an... with ADHD often find it challenging to focus and ...
(Date:5/8/2008)...FirstCall/ -- Siemens Healthcare and,Laboratory Co...y announced,that they have entered a non-exclusive...evelop new clinical diagnostic tests in the areas ...logy and diabetes. Under the,agreement, initial di...could make the biggest impact to patient care., (...
(Date:5/8/2008)...eeting of the American Pain Society ...wswire/ -- Patients treated with lacosamide,demons...thic pain (DNP),compared to placebo-treated patie...l meeting of the American Pain Society (APS) in Ta...trial of a diabetic neuropathic,pain treatment pro...
(Date:5/8/2008)...-FirstCall/ -- AstraZeneca (NYSE:,AZN) today annou...lication,(sNDA) to the U.S. Food and Drug Administ...ate) Extended-Release Tablets to seek approval for...D), including maintenance of,antianxiety effect. I...n,atypical antipsychotic medicine in GAD. The subm...
Breaking Medicine Technology:Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists 2Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists 3Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists 4Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists 5Siemens and LabCorp Enter Agreement to Co-Develop New Clinical Diagnostic Tests 2Siemens and LabCorp Enter Agreement to Co-Develop New Clinical Diagnostic Tests 3Siemens and LabCorp Enter Agreement to Co-Develop New Clinical Diagnostic Tests 4New Lacosamide Data Provides Evidence for Long-Term Efficacy in Diabetic Neuropathic Pain 2New Lacosamide Data Provides Evidence for Long-Term Efficacy in Diabetic Neuropathic Pain 3New Lacosamide Data Provides Evidence for Long-Term Efficacy in Diabetic Neuropathic Pain 4AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines 2AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines 3AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines 4AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines 5AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines 6AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines 7AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines 8McMaster test detects the most prevalent respiratory viruses 10289 1McMaster test detects the most prevalent respiratory viruses 10289 2Millennium Biotechnologies Group Reports 40 25 Sales Increase for Resurgex Product Line in Greek Market 2785 1Millennium Biotechnologies Group Reports 40 25 Sales Increase for Resurgex Product Line in Greek Market 2785 2Liquent Insight Publisher 3 6 Delivers Advanced Submission Capabilities 10286 1Liquent Insight Publisher 3 6 Delivers Advanced Submission Capabilities 10286 2Drop of Flu Vaccine Under Tongue Bars Infection 10284 1Drop of Flu Vaccine Under Tongue Bars Infection 10284 2
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
Medicine Products: